PET/MRI scans for rectal cancer
Part of Cancer, Digestive system clinical trials.
This study uses PET/MRI scans to look at rectal cancer in detail. It may help doctors plan treatment more accurately. The study is for people with stage 2-3 rectal cancer who will get chemotherapy and radiation before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have rectal cancer that is confirmed by biopsy and has not spread to other parts of the body.
- Your rectal tumor is within 16 cm of the anal opening and is at a certain stage (stage 2 or 3).
- You are healthy enough to receive chemotherapy and radiation before surgery.
- You are 18 years or older.
- You can have an MRI (no metal implants like pacemakers or cochlear implants).
- You have not had prior radiation or chemotherapy to the pelvis.
- If you can become pregnant, you must use effective birth control and not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a special scan called PET-MRI can better show how rectal cancer responds to treatment given before surgery. If it works well, it could help doctors plan the right next steps after chemoradiotherapy.
This study looks at how an MRI “score” (mrTRG) matches how well locally advanced rectal cancer shrinks after pre-surgery chemotherapy and radiation. The goal is to use MRI results to better predict treatment response and guide care.
This trial compares two imaging techniques, a new type of PET/MRI with a special tracer called FAPI versus a standard tracer called FDG, to see which is better at detecting spread of rectal cancer to nearby lymph nodes. The results may help doctors choose the best scan for planning your surgery.
This trial uses a special type of MRI scan (called amide proton transfer-weighted imaging) to look at your rectal cancer before and after chemotherapy and/or radiation. The goal is to see if the scan can predict whether the cancer has completely disappeared by the time of surgery, which could help guide future treatment decisions.
This study uses MRI scans to try to predict whether your rectal cancer completely disappears after pre-surgery chemoradiotherapy. The goal is to better personalize treatment decisions, possibly helping some patients avoid surgery.
This study tests a new MRI-guided approach to treat rectal cancer without removing the rectum, aiming to preserve quality of life. It may be an option for patients with stage II or III rectal cancer who are healthy enough for intensive treatment.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.